Bioject Dissatisfied With Panel Discussion On Jet Injector Guidance
This article was originally published in The Gray Sheet
Executive Summary
Bioject Medical Technologies will be looking for more concrete guidance from FDA than was delivered by the agency's General Hospital and Personal Use Devices Advisory Panel, prior to pursuing approval for specific applications for the Biojector jet injector, the firm says.